908 related articles for article (PubMed ID: 32999081)
1. Antimicrobial Peptide Exposure Selects for Resistant and Fit Stenotrophomonas maltophilia Mutants That Show Cross-Resistance to Antibiotics.
Blanco P; Hjort K; Martínez JL; Andersson DI
mSphere; 2020 Sep; 5(5):. PubMed ID: 32999081
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms and phenotypic consequences of acquisition of tigecycline resistance by Stenotrophomonas maltophilia.
Blanco P; Corona F; Martinez JL
J Antimicrob Chemother; 2019 Nov; 74(11):3221-3230. PubMed ID: 31369109
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Peptide Combination Can Hinder Resistance Evolution.
Maron B; Rolff J; Friedman J; Hayouka Z
Microbiol Spectr; 2022 Aug; 10(4):e0097322. PubMed ID: 35862981
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of antimicrobial resistance in
Gil-Gil T; Martínez JL; Blanco P
Expert Rev Anti Infect Ther; 2020 Apr; 18(4):335-347. PubMed ID: 32052662
[No Abstract] [Full Text] [Related]
5. Involvement of the RND efflux pump transporter SmeH in the acquisition of resistance to ceftazidime in Stenotrophomonas maltophilia.
Blanco P; Corona F; Martínez JL
Sci Rep; 2019 Mar; 9(1):4917. PubMed ID: 30894628
[TBL] [Abstract][Full Text] [Related]
6. Review on
Majumdar R; Karthikeyan H; Senthilnathan V; Sugumar S
Recent Pat Biotechnol; 2022; 16(4):329-354. PubMed ID: 35549857
[TBL] [Abstract][Full Text] [Related]
7. Multidrug-resistant Stenotrophomonas maltophilia: Description of new MLST profiles and resistance and virulence genes using whole-genome sequencing.
Rizek CF; Jonas D; Garcia Paez JI; Rosa JF; Perdigão Neto LV; Martins RR; Moreno LZ; Rossi Junior A; Levin AS; Costa SF
J Glob Antimicrob Resist; 2018 Dec; 15():212-214. PubMed ID: 30036694
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of SmeGH contributes to the acquired MDR of Stenotrophomonas maltophilia.
Li LH; Zhang MS; Wu CJ; Lin YT; Yang TC
J Antimicrob Chemother; 2019 Aug; 74(8):2225-2229. PubMed ID: 31086945
[TBL] [Abstract][Full Text] [Related]
9. Characterization of phage evolution and phage resistance in drug-resistant
Han P; Lin W; Fan H; Tong Y
J Virol; 2024 Feb; 98(2):e0124923. PubMed ID: 38189285
[TBL] [Abstract][Full Text] [Related]
10. Fosfomycin Resistance Evolutionary Pathways of
Gil-Gil T; Martínez JL
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163052
[TBL] [Abstract][Full Text] [Related]
11. Detection of multidrug resistant environmental isolates of
Govender R; Amoah ID; Kumari S; Bux F; Stenström TA
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2021; 56(2):213-225. PubMed ID: 33378222
[No Abstract] [Full Text] [Related]
12. Mechanisms and consequences of bacterial resistance to antimicrobial peptides.
Andersson DI; Hughes D; Kubicek-Sutherland JZ
Drug Resist Updat; 2016 May; 26():43-57. PubMed ID: 27180309
[TBL] [Abstract][Full Text] [Related]
13. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
[TBL] [Abstract][Full Text] [Related]
14. Stenotrophomonas maltophilia drug resistance.
Sanchez MB; Hernandez A; Martinez JL
Future Microbiol; 2009 Aug; 4(6):655-60. PubMed ID: 19659422
[TBL] [Abstract][Full Text] [Related]
15. Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia.
Pompilio A; Crocetta V; Scocchi M; Pomponio S; Di Vincenzo V; Mardirossian M; Gherardi G; Fiscarelli E; Dicuonzo G; Gennaro R; Di Bonaventura G
BMC Microbiol; 2012 Jul; 12():145. PubMed ID: 22823964
[TBL] [Abstract][Full Text] [Related]
16. Interplay between intrinsic and acquired resistance to quinolones in Stenotrophomonas maltophilia.
García-León G; Salgado F; Oliveros JC; Sánchez MB; Martínez JL
Environ Microbiol; 2014 May; 16(5):1282-96. PubMed ID: 24447641
[TBL] [Abstract][Full Text] [Related]
17. Multidrug-resistant Stenotrophomonas maltophilia in residential aged care facilities: An emerging threat.
Sapula SA; Hart BJ; Siderius NL; Amsalu A; Blaikie JM; Venter H
Microbiologyopen; 2024 Jun; 13(3):e1409. PubMed ID: 38682784
[TBL] [Abstract][Full Text] [Related]
18. Integrated evolutionary analysis reveals antimicrobial peptides with limited resistance.
Spohn R; Daruka L; Lázár V; Martins A; Vidovics F; Grézal G; Méhi O; Kintses B; Számel M; Jangir PK; Csörgő B; Györkei Á; Bódi Z; Faragó A; Bodai L; Földesi I; Kata D; Maróti G; Pap B; Wirth R; Papp B; Pál C
Nat Commun; 2019 Oct; 10(1):4538. PubMed ID: 31586049
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial therapy for Stenotrophomonas maltophilia infections.
Nicodemo AC; Paez JI
Eur J Clin Microbiol Infect Dis; 2007 Apr; 26(4):229-37. PubMed ID: 17334747
[TBL] [Abstract][Full Text] [Related]
20. Multiple antibiotic resistance in Stenotrophomonas maltophilia: involvement of a multidrug efflux system.
Zhang L; Li XZ; Poole K
Antimicrob Agents Chemother; 2000 Feb; 44(2):287-93. PubMed ID: 10639352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
